Saturday, 1 November 2014 - 17:26

Tomorrow activists from the Treatment Action Campaign and SECTION27 will run the Soweto Marathon wearing their distinctive HIV positive vests, singing, and handing out condoms on route. The Soweto Marathon marks the start of a month long fundraising drive, which aims to raise much needed funds to continue the critical work of the TAC. Back in 2012 the TAC formed a famous 'bus' in the Soweto Marathon made up of over 100 people. This helped a group of runners living with HIV to sing and run to the finish line of their first ever marathon. A victory on many levels!
Below we hear...

Read more
Saturday, 1 November 2014 - 16:16

JOHANNESBURG, 1st NOVEMBER 2014: The Treatment Action Campaign (TAC) and SECTION27 would like to congratulate Justice Edwin Cameron, who will tonight be accorded honorary membership of the Johannesburg Bar. This great honour has only been conferred on five other people, namely, Arthur Chaskalson, Sir Sydney Kentridge, George Bizos, Jules Browde and Johann Kriegler. Joining people of such great stature bears testimony to his integrity, lifelong dedication and unwavering commitment to the law as a vehicle for social change and justice.
Justice Cameron has been pivotal...

Read more
Friday, 31 October 2014 - 16:55

BARCELONA, 31st October 2014: A WHO and Global Fund study revealed that for the period between 2014 and 2016, there will be a funding shortfall for TB activities totaling up to US$ 1.6 billion/year, assuming that US$ 3.2 billion/year will be met through domestic financing. This figure however does not include the US$ 2billion/year needed for R&D investments as recommended by the Stop TB Partnership’s Global Plan to Stop TB, of which only a third is invested each year. Once we include the R&D funding requirements, we arrive at an estimated funding gap of US$ 2.9...

Read more
Friday, 31 October 2014 - 08:56

BARCELONA, OCTOBER 30th, 2014 —Members of the Treatment Action Campaign (TAC) joined activists from across the world who interrupted the Japanese pharmaceutical company Otsuka’s symposium at the 45th Conference on Lung Health, calling for immediate broad compassionate use access to delamanid, Otsuka’s new drug to treat multidrug-resistant TB (MDR-TB).  
Activists called attention to the contrast between delamanid’s limited availability here on earth and Otsuka’s plan to launch its sports drink on the moon. In 2015, Otsuka plans to send a canister filled with its...

Read more
Thursday, 30 October 2014 - 08:37

BARCELONA, 29th OCTOBER 2014: Today at the opening plenary of the 45th Conference on Lung Health in Barcelona, activists from across the globe called on governments to dramatically increase spending on research and development (R&D) for new treatments for tuberculosis (TB). Treatment options for people with multidrug-resistant TB (MDR-TB) are particularly challenging. Spending must be tripled to meet the US$2 billion annual minimum required according to the Stop TB Partnership’s Global Plan to Stop TB.
The message was delivered by Portia Serote, a TB...

Read more